Latin America Gastroretentive Drug Delivery Systems Market Size & Outlook

The gastroretentive drug delivery systems market in Latin America is expected to reach a projected revenue of US$ 1,289.1 million by 2028. A compound annual growth rate of 5.9% is expected of Latin America gastroretentive drug delivery systems market from 2022 to 2028.

Revenue, 2021 (US$M)
$863.1
Forecast, 2028 (US$M)
$1,289.1
CAGR, 2022 - 2028
5.9%
Report Coverage
Latin America

Latin America gastroretentive drug delivery systems market, 2016-2028 (US$M)

Latin

Latin America gastroretentive drug delivery systems market highlights

  • The Latin America gastroretentive drug delivery systems market generated a revenue of USD 863.1 million in 2021.
  • The market is expected to grow at a CAGR of 5.9% from 2022 to 2028.
  • In terms of segment, floating drug delivery system and was the largest revenue generating type in 2021.
  • Bioadhesive Drug Delivery System is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, Brazil is expected to register the highest CAGR from 2022 to 2028.


Latin America data book summary

Market revenue in 2021USD 863.1 million
Market revenue in 2028USD 1,289.1 million
Growth rate5.9% (CAGR from 2021 to 2028)
Largest segmentFloating drug delivery system and
Fastest growing segmentBioadhesive Drug Delivery System
Historical data covered2016 - 2020
Base year for estimation2021
Forecast period covered2022 - 2028
Quantitative unitsRevenue in USD million
Market segmentationFloating Drug Delivery System and, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High density systems
Key market players worldwideRoche Holding AG ADR, GSK PLC, Alcon Inc, Ranbaxy Laboratories, Pharmacia, Lupin, Galaxy Digital Holdings Ltd, Sun Pharma Advanced Research Company


Other key industry trends

  • In terms of revenue, Latin America region accounted for 6.8% of the global gastroretentive drug delivery systems market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2028.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 4,620.4 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gastroretentive Drug Delivery Systems Market Companies

Name Profile # Employees HQ Website

Latin America gastroretentive drug delivery systems market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gastroretentive drug delivery systems market will help companies and investors design strategic landscapes.


Floating drug delivery system and was the largest segment with a revenue share of 45.51% in 2021. Horizon Databook has segmented the Latin America gastroretentive drug delivery systems market based on floating drug delivery system and, expandable drug delivery system, bioadhesive drug delivery system, high density systems covering the revenue growth of each sub-segment from 2016 to 2028.


Reasons to subscribe to Latin America gastroretentive drug delivery systems market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America gastroretentive drug delivery systems market databook

  • Our clientele includes a mix of gastroretentive drug delivery systems market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America gastroretentive drug delivery systems market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America gastroretentive drug delivery systems market from 2016 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Latin America gastroretentive drug delivery systems market size, by country, 2016-2028 (US$M)

Latin America Gastroretentive Drug Delivery Systems Market Outlook Share, 2021 & 2028 (US$M)

Latin America gastroretentive drug delivery systems market size, by country, 2016-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more